Selective estrogen receptor agonism lacks clinical benefit in rheumatoid arthritis: comment on the article by van Vollenhoven et al

Arthritis Rheum. 2010 Dec;62(12):3832-3. doi: 10.1002/art.27722.
No abstract available

Publication types

  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Estrogen Receptor beta / agonists*
  • Humans
  • Oxazoles / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • ERB 041
  • Estrogen Receptor beta
  • Oxazoles